These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21396956)

  • 1. CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
    Alex AB; Saunders GW; Dalpé-Charron A; Reilly CA; Wilcox KS
    Neurotoxicology; 2011 Aug; 32(4):392-9. PubMed ID: 21396956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME; White HS; Wilcox KS
    Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors.
    Donevan SD; McCabe RT
    Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
    Klein RC; Prorok M; Galdzicki Z; Castellino FJ
    J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression.
    Barton ME; White HS
    Epilepsy Res; 2004 Mar; 59(1):1-12. PubMed ID: 15135162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death.
    Martel MA; Wyllie DJ; Hardingham GE
    Neuroscience; 2009 Jan; 158(1):334-43. PubMed ID: 18378405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
    Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ
    Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonists.
    Dave JR; Williams AJ; Moffett JR; Koenig ML; Tortella FC
    Neurotox Res; 2003; 5(4):255-64. PubMed ID: 12835117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity.
    Ortinau S; Laube B; Zimmermann H
    J Neurosci; 2003 Jun; 23(12):4996-5003. PubMed ID: 12832522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
    Sheng Z; Prorok M; Castellino FJ
    Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
    Buller AL; Monaghan DT
    Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
    Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective vulnerability of hippocampal cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the expression of polyamine-sensitive N-methyl-D-asparate-type glutamate receptors.
    Butler TR; Self RL; Smith KJ; Sharrett-Field LJ; Berry JN; Littleton JM; Pauly JR; Mulholland PJ; Prendergast MA
    Neuroscience; 2010 Jan; 165(2):525-34. PubMed ID: 19837138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.
    Matteucci A; Cammarota R; Paradisi S; Varano M; Balduzzi M; Leo L; Bellenchi GC; De Nuccio C; Carnovale-Scalzo G; Scorcia G; Frank C; Mallozzi C; Di Stasi AM; Visentin S; Malchiodi-Albedi F
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1070-7. PubMed ID: 20861489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.